gatifloxacin has been researched along with Prostatitis in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Prostatitis: Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The gatifloxacin treatment resulted in significant reductions in the scores on the JPN-NIH CPSI." | 6.73 | Gatifloxacin treatment for chronic prostatitis: a prospective multicenter clinical trial. ( Hirose, T; Horita, H; Iwasawa, A; Koroku, M; Kunishima, Y; Matsukawa, M; Nishimura, M; Suzuki, N; Takahashi, S; Takeda, K; Takeyama, K; Tanaka, T; Tanda, H; Tsukamoto, T; Yokoo, A, 2008) |
| "To investigate the efficacy and safety of gatifloxacin (400mg/day) on chronic prostatitis or cystitis, 453 patients with prostatitis (NIH category II or IIIa) (N=149, mean 45." | 3.73 | Efficacy and safety of gatifloxacin for urinary tract infection in nonspecialized Korean urologic practice. ( Cho, IR; Cho, YH; Choo, MS; Hwang, TK; Kim, CI; Kim, CS; Kim, ME; Kim, MH; Kim, YG; Lee, KS; Lee, SD; Lee, SJ; Rhew, HY; Ryu, SB; Shim, BS; Sung, LH; Yoon, DK, 2006) |
| "The gatifloxacin treatment resulted in significant reductions in the scores on the JPN-NIH CPSI." | 2.73 | Gatifloxacin treatment for chronic prostatitis: a prospective multicenter clinical trial. ( Hirose, T; Horita, H; Iwasawa, A; Koroku, M; Kunishima, Y; Matsukawa, M; Nishimura, M; Suzuki, N; Takahashi, S; Takeda, K; Takeyama, K; Tanaka, T; Tanda, H; Tsukamoto, T; Yokoo, A, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunishima, Y | 1 |
| Takeyama, K | 1 |
| Takahashi, S | 1 |
| Matsukawa, M | 1 |
| Koroku, M | 1 |
| Tanda, H | 1 |
| Tanaka, T | 1 |
| Hirose, T | 1 |
| Iwasawa, A | 1 |
| Nishimura, M | 1 |
| Takeda, K | 1 |
| Suzuki, N | 1 |
| Horita, H | 1 |
| Yokoo, A | 1 |
| Tsukamoto, T | 1 |
| Lee, SD | 1 |
| Lee, SJ | 1 |
| Hwang, TK | 1 |
| Yoon, DK | 1 |
| Lee, KS | 1 |
| Sung, LH | 1 |
| Choo, MS | 1 |
| Shim, BS | 1 |
| Cho, IR | 1 |
| Kim, ME | 1 |
| Ryu, SB | 1 |
| Kim, CS | 1 |
| Kim, YG | 1 |
| Kim, CI | 1 |
| Rhew, HY | 1 |
| Kim, MH | 1 |
| Cho, YH | 1 |
1 trial available for gatifloxacin and Prostatitis
| Article | Year |
|---|---|
Gatifloxacin treatment for chronic prostatitis: a prospective multicenter clinical trial.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle | 2008 |
1 other study available for gatifloxacin and Prostatitis
| Article | Year |
|---|---|
Efficacy and safety of gatifloxacin for urinary tract infection in nonspecialized Korean urologic practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cystitis; Female; Fluoroquinolones; Gatifloxacin; Humans | 2006 |